pharma · Advanced Cancer · Advanced Solid Tumors · TCRT
Alaunos Therapeutics
Alaunos Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
8030 El Rio St, Houston, Texas 77054, US HQ
10 Employees
Public company Type
TCRT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 8030 El Rio St, Houston, Texas 77054, US
- Employees
- 10
- Programs
- 34
- Drugs
- 12
- Patents
- 0
Alaunos Therapeutics patents
0 pharmaceutical patents indexed for Alaunos Therapeutics. 0 expire within 24 months.
Alaunos Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Alaunos Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Alaunos Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.